Immunocore Holdings plc
Net SellingIMCR·US·🇺🇸 US
39%buys·61%sales
144 transactions$144.0MTotal buys·24 buys
$918.8MTotal sells·38 sells
1818 insiders
Last: Dec 5, 2025
| Date | Insider | Type | Value | |
|---|---|---|---|---|
| Dec 5, 25 | Berman David M | Exercise | - | |
| Dec 5, 25 | Berman David M | Exercise | $10K | |
| Dec 5, 25 | Berman David M | Sell | $23K | |
| Dec 4, 25 | Berman David M | Exercise | - | |
| Dec 4, 25 | Berman David M | Sell | $1.3M | |
| Dec 4, 25 | Berman David M | Exercise | $547K | |
| Nov 28, 25 | Berman David M | Exercise | - | |
| Nov 28, 25 | Berman David M | Exercise | $96K | |
| Nov 28, 25 | Berman David M | Sell | $221K | |
| Nov 26, 25 | Berman David M | Exercise | - |
Immunocore Holdings plc (IMCR) has recorded 144 insider transactions from 18 insiders. Total insider buying volume stands at $144.0M, while total selling volume is $918.8M. Overall insider sentiment is bearish (61% sales).
Immunocore Holdings plc (IMCR) has recorded 144 insider operations, including 24 open-market purchases ($144.0M), 38 sales ($918.8M) and 82 other operations (stock option exercises, grants, tax dispositions, donations). The insider sentiment is bearish (61% sales).
Immunocore Holdings plc shows moderate insider activity with 7 active months out of the last 12, typical of a company whose trading windows are concentrated around financial disclosures.
Among the most active insiders are Jallal Bahija (CEO), Di Donato Brian (CFO) & Coy Travis Alan (CFO), with respectively 21, 3, 1 transactions.
Across all 144 recorded transactions, the breakdown by type is: grant (50, 35%), sales (38, 26%), exercise (32, 22%), buys (24, 17%).
Data sourced from regulatory filings (SEC Form 4, AMF, BaFin, FI, and other European authorities).
Immunocore Holdings plc has recorded 144 insider operations in total, including 24 open-market purchases ($144.0M), 38 sales ($918.8M) and 82 other operations (stock option exercises, grants, tax dispositions, donations). The most recent transaction was recorded on December 5, 2025.
Insiders at Immunocore Holdings plc are currently net sellers, with 39% purchases and 61% sales across all reported transactions. Total buy volume is $144.0M versus $918.8M in sales, indicating a bearish insider sentiment.
InsiderLens tracks 18 insiders at Immunocore Holdings plc (IMCR). Jallal Bahija (CEO, 21 tx), Di Donato Brian (CFO, 3 tx), Coy Travis Alan (CFO, 1 tx). Data is sourced from mandatory regulatory filings for persons with access to privileged information.
The insider signal for IMCR is bearish, based on a 39% buy ratio across 62 buy and sell transactions reported to financial regulators. Transactions from C-suite executives (CEO, CFO) and board members are generally considered the most informative signals.
Insider trading data for Immunocore Holdings plc comes from official regulatory filings: SEC Form 4 (United States), AMF (France), BaFin (Germany), FI (Sweden), and other European financial authorities. These filings are mandatory for directors, officers, and holders of more than 10% of a company's shares. InsiderLens aggregates and normalizes this data for analysis.